Genomes.io, a London, UK-based biotech company focused on the safe, private, and auditable monetization of genomic data, received a USD20m commitment from Bahamas-based digital asset investment firm GEM Digital Limited.
The commitment will allow the company to accelerate its technological growth.
Founded in London in 2018 by Aldo de Pape, CEO, Genomes.io is a secure DNA data storage and sharing application that allows users to sequence, store and commercialize their genomic data & enables biotech and pharmaceutical organizations to access genomic data equitably. Since its conception, the company has been developing its infrastructure with partners such as AMD and ConsenSys to ensure the safe storage, querying, and management of genomic data.
In 2022, Genomes.io won the Deloitte Tech Fast 50 Challenge Award for being the most innovative and disruptive Web3 technology in the healthcare sector, and earlier this month, it directly compensated its vault holders for scientific research to advance genomic insights into long COVID in an anonymous manner.
FinSMEs
21/08/2023